CA2183557A1 - Formule d'un aerosol medicamenteux contenant de la vitamine e - Google Patents
Formule d'un aerosol medicamenteux contenant de la vitamine eInfo
- Publication number
- CA2183557A1 CA2183557A1 CA002183557A CA2183557A CA2183557A1 CA 2183557 A1 CA2183557 A1 CA 2183557A1 CA 002183557 A CA002183557 A CA 002183557A CA 2183557 A CA2183557 A CA 2183557A CA 2183557 A1 CA2183557 A1 CA 2183557A1
- Authority
- CA
- Canada
- Prior art keywords
- tocopherol
- pharmaceutical composition
- propellant
- composition according
- alpha tocopherol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composition pharmaceutique pour aérosols comprenant: (a) un médicament, (b) un propulseur n'étant pas du fluorocarbone, (c) du tocophérol ou l'un de ses dérivés pharmacocompatibles, et procédé de préparation de ladite composition prévenant la formation d'agrégats de médicament sans recourir à des surfactants ou à des cosolvants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21247294A | 1994-03-14 | 1994-03-14 | |
US08/212,472 | 1994-03-14 | ||
PCT/US1995/002764 WO1995024892A1 (fr) | 1994-03-14 | 1995-03-02 | Formule d'un aerosol medicamenteux contenant de la vitamine e |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2183557A1 true CA2183557A1 (fr) | 1995-09-21 |
Family
ID=22791169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002183557A Abandoned CA2183557A1 (fr) | 1994-03-14 | 1995-03-02 | Formule d'un aerosol medicamenteux contenant de la vitamine e |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0804157A1 (fr) |
JP (1) | JPH09510445A (fr) |
KR (1) | KR970701535A (fr) |
AU (1) | AU709783B2 (fr) |
CA (1) | CA2183557A1 (fr) |
IL (1) | IL112897A0 (fr) |
WO (1) | WO1995024892A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9409778D0 (en) | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
EP0914143A1 (fr) * | 1996-07-08 | 1999-05-12 | Rhone-Poulenc Rorer Limited | Formulation d'une solution d'aerosol medicinal de cyclosporine a |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6193954B1 (en) | 1997-03-21 | 2001-02-27 | Abbott Laboratories | Formulations for pulmonary delivery of dopamine agonists |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
EP1458360B1 (fr) | 2001-12-19 | 2011-05-11 | Novartis AG | Administration pulmonaire d'aminoglycosides |
DE102006051512A1 (de) | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9024365D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
DE69231991T2 (de) * | 1991-06-10 | 2002-04-04 | Schering Corp | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen |
PT656207E (pt) * | 1991-06-10 | 2001-11-30 | Schering Corp | Formulacoes de aerossois sem clorofluorocarbonetos |
ATE128350T1 (de) * | 1991-12-12 | 1995-10-15 | Glaxo Group Ltd | Pharmazeutische aerosolformulierung. |
ATE150296T1 (de) * | 1991-12-18 | 1997-04-15 | Minnesota Mining & Mfg | Aerosolzusammensetzungen für arzneimittelsuspensionen |
DE4203306A1 (de) * | 1992-02-06 | 1993-08-12 | Ig Spruehtechnik Gmbh | Asthma oder pulmonal-aerosolzubereitungen mit lecithin |
US5301664A (en) * | 1992-03-06 | 1994-04-12 | Sievers Robert E | Methods and apparatus for drug delivery using supercritical solutions |
DE4230876A1 (de) * | 1992-03-17 | 1993-09-23 | Asta Medica Ag | Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten |
-
1995
- 1995-03-02 CA CA002183557A patent/CA2183557A1/fr not_active Abandoned
- 1995-03-02 JP JP7524061A patent/JPH09510445A/ja not_active Withdrawn
- 1995-03-02 AU AU19804/95A patent/AU709783B2/en not_active Ceased
- 1995-03-02 EP EP95912746A patent/EP0804157A1/fr not_active Withdrawn
- 1995-03-02 KR KR1019960705052A patent/KR970701535A/ko not_active Application Discontinuation
- 1995-03-02 WO PCT/US1995/002764 patent/WO1995024892A1/fr not_active Application Discontinuation
- 1995-03-06 IL IL11289795A patent/IL112897A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU1980495A (en) | 1995-10-03 |
AU709783B2 (en) | 1999-09-09 |
JPH09510445A (ja) | 1997-10-21 |
MX9604004A (es) | 1997-12-31 |
KR970701535A (ko) | 1997-04-12 |
EP0804157A1 (fr) | 1997-11-05 |
WO1995024892A1 (fr) | 1995-09-21 |
IL112897A0 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0731688B1 (fr) | Compositions medicamenteuses en aerosol pour utilisation avec des gaz propulseurs sans cfc | |
US5635159A (en) | Aerosol drug formulations containing polyglycolyzed glycerides | |
AU749697B2 (en) | Medicinal aerosol formulations | |
US5635161A (en) | Aerosol drug formulations containing vegetable oils | |
US6461591B1 (en) | Medical aerosol formulations | |
KR100275426B1 (ko) | 가압 에어로솔 조성물 | |
ES2358293T3 (es) | Formulaciones de aerosol de diisobutirilapomorfina. | |
EP0617610B1 (fr) | Formulations d'aerosol en suspension | |
ES2292713T3 (es) | Formulaciones medicinales en aerosol. | |
EP1306082B1 (fr) | Aérosols doseurs sous pression et compositions pharmaceutiques d'aérosol | |
AU3523199A (en) | Pharmaceutical aerosol formulation | |
US6193954B1 (en) | Formulations for pulmonary delivery of dopamine agonists | |
CA2183557A1 (fr) | Formule d'un aerosol medicamenteux contenant de la vitamine e | |
US7186402B2 (en) | Medicinal aerosol compositions with an amide and/or ester containing excipient compound | |
AU630669B2 (en) | A nedocromil sodium aerosol composition containing flavouring and/or sweetening agents | |
MXPA96004004A (en) | Formulations of aerosol drugs containing vitamin | |
KR0175164B1 (ko) | 에어로졸 약물 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |